Naturland Holding Zrt (BUD:NATURLAND) EBITDA Margin % : 28.17% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Naturland Holding Zrt EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Naturland Holding Zrt's EBITDA for the six months ended in Jun. 2024 was Ft829 Mil. Naturland Holding Zrt's Revenue for the six months ended in Jun. 2024 was Ft2,943 Mil. Therefore, Naturland Holding Zrt's EBITDA margin for the quarter that ended in Jun. 2024 was 28.17%.

Naturland Holding Zrt EBITDA Margin % Historical Data

The historical data trend for Naturland Holding Zrt's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturland Holding Zrt EBITDA Margin % Chart

Naturland Holding Zrt Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

97.22

27.93

30.25

27.89

Naturland Holding Zrt Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial			30.50	30.02	29.02	26.87	28.17

Competitive Comparison of Naturland Holding Zrt's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturland Holding Zrt's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Naturland Holding Zrt's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Naturland Holding Zrt EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Naturland Holding Zrt's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1558.445	/	5587.992
	=	27.89 %

Naturland Holding Zrt's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	829.13	/	2943.03
	=	28.17 %

Naturland Holding Zrt (BUD:NATURLAND) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Naturland Holding Zrt EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Naturland Holding Zrt's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Naturland Holding Zrt Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Naturland Holding Zrt (BUD:NATURLAND) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Csillagvirag utca 8, Budapest, HUN, 1106

Website

https://www.naturlandholding.hu

Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.

Naturland Holding Zrt Headlines

No Headlines